Supplementary Table 1 from Trastuzumab Has Preferential Activity against Breast Cancers Driven by HER2 Homodimers
crossref(2023)
摘要
Supplementary Table 1 from Trastuzumab Has Preferential Activity against Breast Cancers Driven by HER2 Homodimers
更多查看译文
AI 理解论文
溯源树
样例
![](https://originalfileserver.aminer.cn/sys/aminer/pubs/mrt_preview.jpeg)
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要